Since serving in the FDA’s Office of Chief Counsel as associate chief counsel for enforcement, Ms. Bragg has represented companies in criminal and civil litigation and strategic regulatory matters. She is frequently called upon to conduct due diligence and related counseling in connection with transactions in the life sciences and health care industries, and has extensive litigation and trial experience.

Ms. Bragg’s primary practice involves advising pharmaceutical and medical device companies in connection with complex regulatory issues in an effort to minimize litigation and enforcement risks, as well as overcome transactional hurdles.